Ai - Articles - Page 43

Optellum raises $14M in series A for lung cancer diagnostic platform

Sep. 27, 2022

Following on a trifecta of regulatory wins, Optellum Ltd. raised $14 million in a series A funding round to commercialize its artificial intelligence (AI)-enabled lung cancer diagnostic platform. Optellum’s Virtual Nodule Clinic, which helps physicians identify and monitor patients at-risk of lung cancer, has received U.S. FDA clearance, CE-MDR in the European Union and UKCA in the U.K.

Skout clearance opens path to better, more consistent colonoscopies

Sep. 23, 2022

By Annette Boyle

Colorectal cancer (CRC) is expected to increase steadily through the decade to reach more than 2.2 million cases and 1.1 million deaths by 2030 as two concurrent trends tick up—an aging population, that typically has higher rates of the disease, and an alarming increase in cases in younger people. Iterative Scopes Inc. hopes to help gastroenterologists find precancerous lesions before they progress with its Skout device, which received U.S. FDA 510(k) clearance this week.

Study validates Volta's AI mapping system for atrial fibrillation

Sep. 22, 2022

By Bernard Banga

Volta Medical SAS reported validation for its VX1 software mapping system, an artificial intelligence (AI) algorithm compatible with most commonly available multi-pole catheters and technology used in operating rooms and cath labs for treating cardiac arrhythmia. Results from the proof-of-concept-study were published in the Journal of Cardiovascular Electrophysiology.

NIH officially launces Bridge2AI for artificial intelligence in biomedical research

Sep. 19, 2022

By Mark McCarty

The U.S. NIH is not generally regarded as a wellspring of concepts and policies in the world of artificial intelligence (AI), but that perception may change soon thanks to the agency’s Bridge2AI program. The agency announced recently that it will drop $130 million into this program over four years in an effort to develop standards for data used in AI research, a key development for device makers seeking to sell products that use these complex algorithms.

Artificial intelligence and digital health icons

NIH officially launches Bridge2AI for artificial intelligence in biomedical research

Sep. 16, 2022

By Mark McCarty

The U.S. NIH is not generally regarded as a wellspring of concepts and policies in the world of artificial intelligence (AI), but that perception may change soon thanks to the agency’s Bridge2AI program. The agency announced recently that it will drop $130 million into this program over four years in an effort to develop standards for data used in AI research, a key development for device makers seeking to sell products that use these complex algorithms.

Regulatory Convergence 2022

Califf still pounding on misinformation despite FDA’s regulatory failures

Sep. 12, 2022

By Mark McCarty

U.S. FDA commissioner Robert Califf resurrected a litany of complaints about medical product misinformation, including vaccinations for the COVID-19 pandemic, in a televised presentation heard by attendees at the Regulatory Affairs Professional Society (RAPS) annual conference here in Phoenix, where the daytime high temperatures are hovering at or near the century mark.

Taiwan FDA clears Brain Navi’s autonomous neurosurgical navigation robot

Sep. 8, 2022

By Tamra Sami

Taiwan's Food and Drug Administration has approved Brain Navi Biotechnology Co. Ltd.’s Naotrac, an autonomous neurosurgical navigation robot that uses artificial intelligence (AI) to map out the most precise surgical pathway for minimal tissue damage to the brain.

AI embryo analysis reduces the time to pregnancy by 12%

Sep. 7, 2022

By Annette Boyle

For the one in eight couples struggling to conceive, the improvements in infertility treatments achieved by employment of artificial intelligence (AI) in diagnostics, personalized therapies and embryo selection may soon mean the difference between childlessness and the family of their dreams.

European Society of Cardiology 2022

Study boosts potential of smartphones to screen for atrial fibrillation

Aug. 30, 2022

By Mark McCarty

Medical science has been experimenting with smart devices for several years to determine whether these products can detect circulatory system diseases, and a study presented at the 2022 meeting of the European Society of Cardiology (ESC 2022) seems to strongly suggest that the answer is a resounding yes. The eBRAVE-AF study of more than 5,500 enrollees of middle age or older demonstrated the ability of a smartphone camera and a downloadable app to at beat conventional screening for atrial fibrillation (AF), a finding that could save lives and boost the prospects of device makers in the digital health space.

European Society of Cardiology 2022

AI software beats physician in test of interpretation of ultrasound for LVEF

Aug. 29, 2022

By Mark McCarty

There may be those who believe that artificial intelligence (AI) is suffering from overexposure in the media, but these software algorithms are nonetheless challenging medical professionals in their use of medical diagnostics. A new study showed that an AI algorithm not only bested the sonographer in interpretation of whether cardiac ultrasound was indicative of left ventricular ejection fraction (LVEF), but also that the results were sufficiently vigorous that the reviewing cardiologist couldn’t distinguish between the sonographer’s interpretations and those provided by the algorithm.